API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212124
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208045
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212244
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208037
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208016
https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-beigene-s-short-seller-attack-sumitomo-roivant-deal-roche-jhl
https://www.fiercebiotech.com/biotech/roivant-lines-up-3b-upfront-sumitomo-dainippon-deal
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208058
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208060
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212091
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208066
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208002
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208002
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208031
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208049
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208055
https://www.businesswire.com/news/home/20181113005407/en/NeuroRx-Receives-FDA-Breakthrough-Therapy-Designation-NRX-101/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
https://www.pharmacompass.com/pdf/news/Latuda-lurasidone-HCl-Sumitomo-D-Pharma-Sunovion-v-Macleods-Pharma-USA-1536920797.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208055
https://www.pharmacompass.com/pdf/news/Latuda-lurasidone-HCl-Sumitomo-Dainippon-Pharma-v-Piramal-Healthcare-UK-1536041780.pdf
https://www.pharmacompass.com/pdf/news/latuda-lurasidone-hcl-sumitomo-dainippon-pharma-v-first-time-us-generics-1520833034.pdf
https://www.pharmacompass.com/pdf/news/latuda-lurasidone-hcl-sumitomo-dainippon-pharma-v-accord-healthcare-1520833093.pdf
https://www.pharmacompass.com/pdf/news/latuda-lurasidone-hcl-sumitomo-dainippon-pharma-v-invagen-pharmaceuticals-1520833252.pdf
https://www.pharmacompass.com/pdf/news/latuda-lurasidone-hcl-sumitomo-dainippon-pharma-v-par-pharmaceutical-1520833507.pdf
https://www.biospace.com/article/fda-grants-sunovion-s-latuda-expanded-approval-for-bipolar-depression-in-pediatric-patients/
https://www.pharmacompass.com/pdf/news/Latuda-Lurasidone-Hcl-Sumitomo-Dainippon-Pharma-v-Emcure-Pharmaceuticals-1520248132.pdf
http://www.pharmatimes.com/news/pharma_companies_fall_foul_of_abpis_code_of_practice_1214319
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208060
http://www.businesswire.com/news/home/20170721005471/en/Sunovion%E2%80%99s-Latuda%C2%AE-lurasidone-HCI-Receives-Health-Canada/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208052
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207948
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/japanese-companies-make-cautious-return-to-indian-pharma-market/articleshow/56320837.cms
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208016
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208028
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208045
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208045
http://www.fiercepharma.com/marketing/october-tv-pharma-ad-spending-abbvie-humira-and-pfizer-lyrica-continue-to-dominate
https://www.pharmacompass.com/pdf/news/accord-healthcares-generic-lurasidone-hcl-receives-tentative-approval-in-us-1476531133.pdf
http://www.fiercepharma.com/marketing/pharma-tv-ad-spending-rises-april-led-by-big-brand-names-from-pfizer-abbvie-and-sunovion
http://www.fiercepharmamarketing.com/story/fake-smiles-star-otsuka-and-lundbecks-dtc-push-rexulti-depression/2016-03-09
http://www.biospectrumasia.com/biospectrum/news/221329/sunovion-announces-positive-results-antipsychotic-drug
http://www.fiercepharmaasia.com/story/takeda-orexigen-end-cv-study-obesity-drug-contrave/2015-05-12
http://www.fiercepharmaasia.com/story/sumitomo-dainippon-takeda-call-it-quits-japan-latuda-agreement/2015-05-07
http://www.fiercepharmaasia.com/story/sumitomo-dainippon-says-latuda-schizophrenia-japan-misses-phiii-aims/2015-04-27
http://www.bloomberg.com/news/articles/2015-03-30/pain-and-erectile-dysfunction-make-pfizer-biggest-in-drug-ads